Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis

Life Sciences

Volumn 85, Issue 13-14, 2009, Pages 517-525

  Chang, Yao Jen ^a   Liu, Jen Wea ^b   Lin, Po Cheng ^b   Sun, Li Yi ^b   Peng, Chih Wen ^c   Luo, Geng Hong ^b   Chen, Tse Min ^d   Lee, Ru Ping ^c   Lin, Shinn Zong ^e   Harn, Horng Jyh ^e,f   Chiou, Tzyy Wen ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bone marrow mesenchymal stem cell; Carbon tetrachloride; Green fluorescent protein; Liver damage; Liver fibrosis; Metalloproteinase

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMMONIA; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; GREEN FLUORESCENT PROTEIN; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BONE MARROW CELL; CELL COUNT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEASIBILITY STUDY; HISTOPATHOLOGY; LIVER BLOOD VESSEL; LIVER FIBROSIS; LIVER INJURY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS;

RATTUS;

EID: 70249138772     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.08.003     Document Type: Article

References (23)

1. Abdel Aziz M.T., Atta H.M., Mahfouz S., Fouad H.H., Roshdy N.K., Ahmed H.H., Rashed L.A., Sabry D., Hassouna A.A., and Hasan N.M. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clinical Biochemistry 40 (2007) 893-899
2. Baksh D., Song L., and Tuan R.S. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. Journal of Cellular and Molecular Medicine 8 3 (2004) 301-316
3. Chen T.M., Subeq Y.M., Lee R.P., Chiou T.W., and Hsu B.G. Single dose intravenous thioacetamide administration as a model of acute liver damage in rats. International Journal of Experimental Pathology 17 (2008) 223-231
4. Corpechot C., Barbu V., Wendum D., Chignard N., Housset C., Poupon R., and Rosmorduc O. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. American Journal of Pathology 160 2 (2002) 613-620
5. Cramer T., Schuppan D., Bauer M., Pfander D., Neuhaus P., and Herbst H. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis. Liver International 24 4 (2004) 335-344
6. Dohi M., Hasegawa T., Yamamoto K., and Marshall B.C. Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 162 6 (2000) 2302-2307
7. Dunsmore S.E., Rubin J.S., Kovacs S.O., Chedid M., Parks W.C., and Welgus H.G. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. Journal of Biological Chemistry 271 40 (1996) 24576-24582
8. Fallowfield J.A., Mizuno M., Kendall T.J., Constandinou C.M., Benyon R.C., Duffield J.S., and Iredale J.P. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. The Journal of Immunology 178 8 (2007) 5288-5295
9. Gutierrez-Reyes G., Gutierrez-Ruiz M.C., and Kershenobich D. Liver fibrosis and chronic viral hepatitis. Archives of Medical Research 38 6 (2007) 644-651
10. Hironaka K., Sakaida I., Matsumura Y., Kaino S., Miyamoto K., and Okita K. Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis. Biochemical and Biophysical Research Communications 267 1 (2000) 290-295
11. Iredale J.P., Shiota G., and Okazaki I. Cirrhosis: new research provides a basis for rational and targeted treatments. British Medical Journal 327 7407 (2003) 143-147
12. Latasa M.U., Boukaba A., Garcia-Trevijano E.R., Torres L., Rodriguez J.L., Caballeria J., Lu S.C., Lopez-Rodas G., Franco L., Mato J.M., and Avila M.A. Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes: role in liver regeneration. Federation of American Societies for Experimental Biology Journal 15 7 (2001) 1248-1250
13. Lee K.D., Kuo T.K., Whang-Peng J., Chung Y.F., Lin C.T., Chou S.H., Chen J.R., Chen Y.P., and Lee O.K. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40 6 (2004) 1275-1284
14. Li W., Liu S.N., Luo D.D., Zhao L., Zeng L.L., Zhang S.L., and Li S.L. Differentiation of hepatocytoid cell induced from whole-bone-marrow method isolated rat myeloid mesenchymal stem cells. World Journal of Gastroenterology 12 30 (2006) 4866-4869
15. Ogura Y., Hamanoue M., Tanabe G., Mitsue S., Yoshidome S., Nuruki K., and Aikou T. Hepatocyte growth factor promotes liver regeneration and protein synthesis after hepatectomy in cirrhotic rats. Hepatogastroenterology 48 38 (2001) 545-549
16. Oyagi S., Hirose M., Kojima M., Okuyama M., Kawase M., Nakamura T., Ohgushi H., and Yagi K. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells int °CCl4-injured rats. Journal of Hepatology 44 4 (2006) 742-748
17. Ozaki I., Zhao G., Mizuta T., Ogawa Y., Hara T., Kajihara S., Hisatomi A., Sakai T., and Yamamoto K. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. Journal of Hepatology 36 2 (2002) 169-178
18. Pepper M.S., Matsumoto K., Nakamura T., Orci L., and Montesano R. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. Journal of Biological Chemistry 267 28 (1992) 20493-20496
19. Schwartz R.E., Reyes M., Koodie L., Jiang Y., Blackstad M., Lund T., Lenvik T., Johnson S., Hu W.S., and Verfaillie C.M. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. The Journal of Clinical Investigation 109 10 (2002) 1291-1302
20. Sun L.Y., Hsieh D.K., Yu T.C., Chiu H.T., Lu S.F., Luo G.H., Kuo T.K., Lee O.K., and Chiou T.W. Effect of pulsed electromagnetic field on the proliferation and differentiation potential of human bone marrow mesenchymal stem cells. Bioelectromagnetics 30 4 (2009) 251-260
21. Zhan Y., Wang Y., Wei L., Chen H., Cong X., Fei R., Gao Y., and Liu F. Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats. Transplant Proceedings 38 9 (2006) 3082-3085
22. Zhao D.C., Lei J.X., Chen R., Yu W.H., Zhang X.M., Li S.N., and Xiang P. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World Journal of Gastroenterology 11 22 (2005) 3431-3440
23. Zwirska-Korczala K., Dziambor A.P., Wiczkowski A., Berdowska A., Gajewska K., and Stolarz W. [Hepatocytes growth factor (HGF), leptin, neopterin serum concentrations in patients with chronic hepatitis C.]. Przegl Epidemiol 55 3 (2001) 164-169